Leveraging automation and data analytics can help facilitate innovation and financial stability.
Whatever the short- and longer-term fallout of COVID-19, organizations will need to come back fighting—with new tools at their disposal and ready to raise their game.
Changes in financial reporting can be an annual disruption for medical device companies. But the impact of recent changes to financial accounting standards is likely the most sweeping since the passage of the Sarbanes Oxley Act of 2002.
It’s too early to tell how the new administration will affect the device industry, but user fees, the ACA and the FDA regulatory process are top of mind.